SIRT6 Inhibits Glycolysis and Cementogenesis via Targeting IRS2
Cell Biology International · 2026-10 · 50 (10)
DOI: 10.1002/cbin.70226 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, online erschienen am 15.10.2026. Verfasst von Liyuan Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, …. Hauptthemen laut MEDLINE: Sirtuins, Glycolysis, Insulin Receptor Substrate Proteins, Dental Cementum. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China, China.
Abstract (Originalsprache)
Cementum shares similar characteristics with bone in terms of biochemical composition. Recent studies have reported that glycolysis is the main energy source driving osteoblast differentiation, but the role of glycolysis in cementoblast differentiation remains elusive. Previously, we found Sirtuin 6 (SIRT6) suppressed cementoblast differentiation and mineralization via inhibiting glucose transporter 1 (GLUT1), indicating that glycolysis may also be required for cementogenesis. However, the underlying mechanisms remain largely unknown. In this study, we observed that the expression of glycolytic enzymes increased progressively during cementoblast differentiation. Measurements of extracellular acidification rate, glucose uptake, lactate release, and gain‐and‐loss of function demonstrated that overexpressing SIRT6 in immortalized mouse cementoblasts (OCCM‐30) suppressed cementoblast glycolysis. Mechanistically, chromatin immunoprecipitation assay results revealed that SIRT6 inhibits insulin receptor substrate 2 (IRS2) transcription by deacetylating histone H3 at lysine K9 (H3K9). Overexpression of IRS2 promoted OCCM‐30 glycolysis and mineralization through phosphoinositide 3‐kinase (PI3K)/protein kinase B (AKT) signaling pathway, whereas SIRT6 significantly inhibited PI3K/AKT pathway activity. Overall, our results demonstrate that SIRT6 inhibits IRS2 transcription by deacetylating histone H3K9, thereby reducing PI3K/AKT signaling‐induced glycolysis and suppressing cementoblast mineralization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Zhejiang Key Laboratory of Oral Biomedical, Hangzhou, Zhejiang, P.R. C…
ORCID-Profile: Liyuan Huang, Jie Shen, Jian Yuan, Peng Deng, Qianming Chen
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China, China
- Major Program of the National Natural Science Foundation of China, China
- National Key R&D Program of China, China
- Development of Science and Technology of Zhejiang Province, China
Zitieren
APA
Huang, L., Shen, J., Cheng, Z., Yuan, J., Deng, P., Fan, L., & Chen, Q. (2026). SIRT6 Inhibits Glycolysis and Cementogenesis via Targeting IRS2. Cell Biology International, 50(10). https://doi.org/10.1002/cbin.70226
Vancouver
Huang L, Shen J, Cheng Z, Yuan J, Deng P, Fan L, et al. SIRT6 Inhibits Glycolysis and Cementogenesis via Targeting IRS2. Cell Biology International. 2026;50(10). doi:10.1002/cbin.70226
BibTeX
@article{Huang2026,
author = {Huang, Liyuan and Shen, Jie and Cheng, Zhebin and Yuan, Jian and Deng, Peng and Fan, Lijie and Chen, Qianming},
title = {SIRT6 Inhibits Glycolysis and Cementogenesis via Targeting IRS2},
journal = {Cell Biology International},
year = {2026},
volume = {50},
number = {10},
doi = {10.1002/cbin.70226}
}
EUVIMED